Levent Sağdur
Levent Sağdur has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Ai Leen Ang
Department of Hematology Singapore General Hospital Singapore
1 shared publication - Angelo Ostuni
Transfusion Medicine, Azienda Ospedaliero-Universitaria Consorziale, Policlinico di Bari, Piazza Giulio Cesare, 70124 Bari, Italy
1 shared publication - Antti Vierikko
Finnish Red Cross Blood Service Helsinki Finland
1 shared publication - Arwa Z. Al-Riyami
Department of Hematology Sultan Qaboos University Hospital, University Medical City Muscat Oman
1 shared publication - Aziz Karaca
Department of Physiology, Faculty of Medicine Recep Tayyip Erdoğan University Rize Turkey
1 shared publication - Carlos Alberto Gonzalez
Servicio de Hemoterapia, Hospital Muñiz, Uspallata 2272, Buenos Aires, Argentina
1 shared publication
Latest Publications
- Open Access
- 13 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Association between ABO/Rh blood groups and transfusion-transmitted infections among Turkish blood donors: a comprehensive demographic analysis (2015–2021)
Background: This study assessed associations between transfusion-transmitted infections (TTIs: hepatitis B, hepatitis C, HIV, syphilis) and demographic factors (sex, age, education) including ABO/Rh blood groups among Turkish blood donors from 2015 to 2021. Methods: A retrospective cross-sectional analysis was performed on 56,766 donors confirmed with any TTI and permanently deferred from donation. The control group comprised 7,229,867 volunteer donors from the same period. Multivariable logistic regression analysis was conducted to assess independent associations between demographic factors and ABO/Rh blood groups with individual TTI risks, adjusting for potential confounders. False Discovery Rate correction was applied for multiple comparisons. Results: Overall TTI prevalence was 0.779%, with HBV being most prevalent (0.594%), followed by syphilis (0.133%), HCV (0.031%), and HIV (0.024%). TTI prevalence decreased significantly over the study period. Male donors showed higher adjusted risk for all TTIs. Lower education levels (≤ 8 years) were associated with increased risk for all infections. Younger donors (18–34 years) had lower prevalence of HBV and syphilis compared to those ≥ 35 years. After FDR correction, several blood group associations remained significant: Blood group B Rh(+) showed increased risk for both HBV (aOR = 1.059, 95% CI: 1.032–1.088) and syphilis (aOR = 1.121, 95% CI: 1.062–1.184). AB Rh(+) donors had increased syphilis risk (aOR = 1.118, 95% CI: 1.035–1.206). Conversely, O Rh(+) showed protective association with syphilis (aOR = 0.855, 95% CI: 0.817–0.895), while A Rh(-) demonstrated protection against HBV (aOR = 0.935, 95% CI: 0.894–0.978). No significant associations were found between blood groups and HCV or HIV infections. Conclusion: This large-scale study demonstrates declining TTI prevalence in Turkish blood donors and identifies demographic risk factors including male sex, older age, and lower education. ABO/Rh blood groups show statistically significant but modest associations with specific TTIs, particularly HBV and syphilis. These findings suggest blood group systems may represent non-modifiable risk factors through complex immunological mechanisms. Comprehensive molecular and genetic studies are needed to elucidate underlying mechanisms and validate these population-specific associations. Clinical trial: Not applicable.
- 13 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessAssociation between ABO/Rh blood groups and transfusion-transmitted infections among Turkish blood donors: a comprehensive demographic analysis (2015–2021)
Background: This study assessed associations between transfusion-transmitted infections (TTIs: hepatitis B, hepatitis C, HIV, syphilis) and demographic factors (sex, age, education) including ABO/Rh blood groups among Turkish blood donors from 2015 to 2021. Methods: A retrospective cross-sectional analysis was performed on 56,766 donors confirmed with any TTI and permanently deferred from donation. The control group comprised 7,229,867 volunteer donors from the same period. Multivariable logistic regression analysis was conducted to assess independent associations between demographic factors and ABO/Rh blood groups with individual TTI risks, adjusting for potential confounders. False Discovery Rate correction was applied for multiple comparisons. Results: Overall TTI prevalence was 0.779%, with HBV being most prevalent (0.594%), followed by syphilis (0.133%), HCV (0.031%), and HIV (0.024%). TTI prevalence decreased significantly over the study period. Male donors showed higher adjusted risk for all TTIs. Lower education levels (≤ 8 years) were associated with increased risk for all infections. Younger donors (18–34 years) had lower prevalence of HBV and syphilis compared to those ≥ 35 years. After FDR correction, several blood group associations remained significant: Blood group B Rh(+) showed increased risk for both HBV (aOR = 1.059, 95% CI: 1.032–1.088) and syphilis (aOR = 1.121, 95% CI: 1.062–1.184). AB Rh(+) donors had increased syphilis risk (aOR = 1.118, 95% CI: 1.035–1.206). Conversely, O Rh(+) showed protective association with syphilis (aOR = 0.855, 95% CI: 0.817–0.895), while A Rh(-) demonstrated protection against HBV (aOR = 0.935, 95% CI: 0.894–0.978). No significant associations were found between blood groups and HCV or HIV infections. Conclusion: This large-scale study demonstrates declining TTI prevalence in Turkish blood donors and identifies demographic risk factors including male sex, older age, and lower education. ABO/Rh blood groups show statistically significant but modest associations with specific TTIs, particularly HBV and syphilis. These findings suggest blood group systems may represent non-modifiable risk factors through complex immunological mechanisms. Comprehensive molecular and genetic studies are needed to elucidate underlying mechanisms and validate these population-specific associations. Clinical trial: Not applicable.
- 20 May 2021
- Published by Wiley in Vox Sanguinis
- Vol. 116 (10) , E71-E120
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses
- 20 May 2021
- Published by Wiley in Vox Sanguinis
- Vol. 116 (10) , E71-E120
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses